Egg Donation — Cost, Top Hospitals & Success Rates | MyMedicPlus

Egg donation is an assisted reproductive technology (ART) in which mature oocytes (eggs) donated by a healthy, screened young woman are fertilised with sperm from the recipient's partner or a sperm donor to create embryos, which are then transferred to the recipient's uterus. Egg donation overcomes the limitation of poor oocyte quality or quantity in the recipient—the primary determinants of IVF success—by using eggs from a donor typically aged 21–35 with good ovarian reserve.

The procedure involves two coordinated participants: the egg donor and the recipient. The donor undergoes controlled ovarian hyperstimulation (COH) followed by transvaginal oocyte retrieval under sedation. The recipient undergoes uterine preparation with oestrogen and progesterone to synchronise her endometrial lining with the donor's cycle. Fertilised embryos (day 3 or blastocyst stage) are transferred to the recipient's uterus in a timed embryo transfer procedure. Supernumerary embryos are cryopreserved for future use.

Egg donation achieves consistently high live birth rates of 45–55% per embryo transfer cycle across recipient age groups—significantly higher than conventional IVF using the patient's own eggs in women over 40—because the success determinant is the donor's egg quality (related to donor age) rather than the recipient's age. This makes egg donation the most effective fertility treatment for women over 42, those with premature ovarian insufficiency (POI), and those with poor responder profiles.

Egg donation is the treatment of choice for premature ovarian insufficiency (POI, also called premature menopause), where the ovaries cease functioning before age 40, depleting the egg supply entirely. Women with severely diminished ovarian reserve (very low AMH, very low antral follicle count) who have had poor or no response to IVF stimulation benefit from donor eggs. Older women (typically over 42–45) with age-related decline in egg quality and quantity—where conventional IVF live birth rates fall below 5–10% per cycle—achieve dramatically improved outcomes with donor eggs.

Genetic disorders where the woman carries a severe X-linked or autosomal condition she does not wish to transmit to offspring—where preimplantation genetic testing (PGT) is not applicable or is declined—are an indication for egg donation using an unaffected donor. Women who have undergone ovarian damage from chemotherapy or radiotherapy for childhood or adult cancer may require egg donation if egg freezing was not performed pre-treatment. Recurrent IVF failure from consistently poor embryo development attributable to oocyte quality may be addressed with donor eggs.

Recipients of egg donation must have an intact, functional uterus capable of sustaining a pregnancy (confirmed by hysteroscopy or saline infusion sonography to rule out uterine cavity abnormalities). There is no strict upper age limit for egg donation in most countries, though many clinics restrict treatment to women under 50–55 given increasing obstetric complications with advanced maternal age. Medical fitness for pregnancy must be established for all recipients, with cardiorespiratory and metabolic assessment for women over 45.

Egg donors are carefully screened young women aged 18–35 with good ovarian reserve (AMH >1.5 ng/mL, AFC >10), who are healthy, have no significant genetic family history, are non-carriers for common autosomal recessive conditions on expanded carrier screening, and are psychologically assessed as understanding the implications of donation. Anonymous donation (common in Spain, Czech Republic, Greece, and much of Asia) versus identity-release donation (mandatory in UK, Australia, New Zealand—donor's identity available to offspring at 18) has significant legal and psychosocial implications and varies by jurisdiction.

Fresh egg donation cycles synchronise the donor's stimulation and egg retrieval with the recipient's endometrial preparation. The donor takes gonadotrophins (FSH with or without LH) for 10–12 days to stimulate multiple follicle development, monitored by serial ultrasound and oestradiol levels. Egg retrieval is performed under ultrasound guidance after hCG or GnRH agonist trigger, under intravenous sedation. Retrieved eggs are fertilised with partner sperm (IVF or ICSI), and resulting embryos cultured to day 3 or day 5 (blastocyst).

Frozen donor egg banks are increasingly used, particularly where anonymous donation is required or where synchronisation is logistically complex. Cryopreserved donor eggs from FDA/CE-compliant egg banks (vitrification technique—a rapid freezing method) are thawed on the day of use, achieving survival rates of 85–95% and clinical outcomes equivalent to fresh donation in experienced hands. The recipient undergoes standard frozen embryo transfer (FET) protocol. Pre-implantation genetic testing (PGT-A) of donor embryos selects euploid embryos, reducing miscarriage rates and improving per-transfer live birth rates to 60–70%. Shared decision-making between the patient and specialist ensures the chosen modality aligns with individual anatomy, comorbidities, risk tolerance, and personal goals. A formal consultation with a board-certified specialist, review of pre-treatment imaging or investigation results, and multidisciplinary team input for complex cases are standard practice before finalising the treatment plan.

Egg donation achieves live birth rates of 45–55% per embryo transfer, consistent across recipient ages because donor age is the primary success determinant. Cumulative live birth rates over 2–3 transfers of cryopreserved embryos from one stimulation cycle reach 70–80% in most series—representing the highest cumulative pregnancy rates of any ART modality. For women over 45, egg donation provides a realistic path to successful pregnancy where autologous IVF offers minimal realistic hope.

Recipients who achieve pregnancy through egg donation report rates of bonding, maternal attachment, and parenting satisfaction equal to women who conceived naturally. The genetic contribution of the donor does not diminish the gestational, epigenetic, and emotional connection built during pregnancy. Disclosure strategies—whether and when to tell the child—are psychosocial considerations supported by counselling but are improving as evidence increasingly supports early, age-appropriate disclosure.

For donors, the main risks are ovarian hyperstimulation syndrome (OHSS), which is minimised by protocol design and occurs as significant OHSS in approximately 1% of donors, and rare complications of egg retrieval (bleeding, infection, bowel or vessel injury). Long-term effects of repeated ovarian stimulation on the donor's future fertility are a theoretical concern—evidence to date does not demonstrate increased long-term infertility or ovarian cancer risk, but comprehensive long-term data are still limited. Emotional and psychological impacts on donors require pre-donation and post-donation counselling.

For recipients, the endometrial preparation and embryo transfer are low-risk procedures. Obstetric risks are higher in egg donation pregnancies than in IVF with own eggs due to recipient age—older recipients have higher rates of gestational hypertension, pre-eclampsia (reported as high as 20–30% in some egg donation series), gestational diabetes, and caesarean delivery. Multiple pregnancy risk is minimised by single embryo transfer. Miscarriage rates after egg donation are lower than after autologous IVF in older women, as chromosomal abnormality rate reflects donor age rather than recipient age.

After embryo transfer, the recipient takes progesterone supplementation (vaginal pessaries and/or injectable progesterone) continuing until 10–12 weeks gestation if pregnancy is established. A pregnancy blood test (hCG) is performed 14 days after transfer, followed by an early pregnancy ultrasound at 6–7 weeks. Progesterone and oestrogen support is gradually tapered after 8–10 weeks as the placenta assumes hormonal production.

Prenatal care for egg donation pregnancies should be undertaken at obstetric units with experience in higher-risk pregnancies given the elevated pre-eclampsia and gestational hypertension risk. The treating fertility clinic provides ongoing liaison with the obstetric team. Psychological support during and after treatment is offered, including counselling regarding disclosure to the child, which is increasingly advocated early and age-appropriately.

Egg donation in the United States costs USD 20,000–50,000 per cycle, including donor compensation (USD 5,000–30,000 is the ASRM-recommended range), fertility clinic fees, medications, and legal fees. In the UK, donor compensation is limited to GBP 750 per cycle under HFEA regulations; total egg donation cycles cost GBP 10,000–18,000. Legal restrictions on compensation in the UK create waiting lists.

Medical tourism for egg donation is particularly well-developed in Spain, the Czech Republic, Greece, Cyprus, and increasingly India and Thailand. Spain offers comprehensive anonymous egg donation cycles including all clinic fees and donor compensation for EUR 5,000–8,000. Czech Republic and Slovakia offer similar programmes at EUR 3,000–5,000. India offers egg donation IVF at USD 2,500–5,000 at ICMR-accredited fertility centres, with a large pool of anonymous egg donors. Patients should research the legal framework at the destination—anonymity requirements, donor compensation limits, and parentage law all vary and require legal advice pre-treatment.

For women with very poor ovarian reserve who wish to attempt pregnancy with their own eggs, IVF with maximal ovarian stimulation (using dual stimulation protocols—both follicular and luteal phase stimulation) can sometimes retrieve sufficient eggs for one embryo transfer, though success rates are low. PGT-A selection of euploid embryos from poor-responder IVF maximises the chance of success from limited embryo numbers.

Embryo adoption (adopting a cryopreserved embryo donated by another couple) provides an alternative to egg donation that involves no stimulation of either donor or recipient, lower costs, and an existing embryo ready for transfer. Gestational surrogacy combined with egg donation allows women who cannot carry a pregnancy (congenital uterine absence, recurrent miscarriage, medical contraindication) to have a child using donor eggs and a surrogate carrier. Adoption and fostering provide non-biological family formation alternatives for couples for whom all fertility treatment options have been exhausted.